166 related articles for article (PubMed ID: 27119230)
1. ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation.
Xing Y; Ge Y; Liu C; Zhang X; Jiang J; Wei Y
Oncotarget; 2016 Jun; 7(24):36395-36406. PubMed ID: 27119230
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
3. Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells.
Ge Y; Zhou F; Chen H; Cui C; Liu D; Li Q; Yang Z; Wu G; Sun S; Gu J; Wei Y; Jiang J
Biochem Biophys Res Commun; 2010 Jul; 397(4):711-7. PubMed ID: 20537983
[TBL] [Abstract][Full Text] [Related]
4. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
Nami B; Donmez H; Kocak N
Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
[TBL] [Abstract][Full Text] [Related]
6. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
7. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
[TBL] [Abstract][Full Text] [Related]
8. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells.
Lee SH; Nam HJ; Kang HJ; Samuels TL; Johnston N; Lim YC
Oncol Rep; 2015 Oct; 34(4):2065-71. PubMed ID: 26239260
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2.
Sun H; Zhang S
Biochem Biophys Res Commun; 2011 Jul; 410(3):692-7. PubMed ID: 21703238
[TBL] [Abstract][Full Text] [Related]
11. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
[TBL] [Abstract][Full Text] [Related]
13. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.
Pietrobono S; Morandi A; Gagliardi S; Gerlini G; Borgognoni L; Chiarugi P; Arbiser JL; Stecca B
J Invest Dermatol; 2016 Oct; 136(10):2059-2069. PubMed ID: 27373978
[TBL] [Abstract][Full Text] [Related]
16. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
17. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
Chou MY; Hu FW; Yu CH; Yu CC
Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
[TBL] [Abstract][Full Text] [Related]
18. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
19. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
20. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.
Bora-Singhal N; Mohankumar D; Saha B; Colin CM; Lee JY; Martin MW; Zheng X; Coppola D; Chellappan S
Sci Rep; 2020 Mar; 10(1):4722. PubMed ID: 32170113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
